Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East Tech Today.
Press releases published on April 4, 2025
Gamer Choice Celebrates 5 Classic Video Games That Defined Childhood for a Generation
EIN Presswire
·
April 4, 2025
Gamer Choice spotlights 5 classic video games that shaped childhoods, bringing nostalgia and timeless fun to today’s gamers. DUBAI, MIDDLE EAST, UNITED ARAB EMIRATES, April 5, 2025 /EINPresswire.com/ -- Gamer Choice, the leading platform for digital …
Suffescom Launches Generative AI Development Services to Help Customers Leverage the Strength of AI
EIN Presswire
·
April 4, 2025
MIDDLETOWN, DE, UNITED STATES, April 4, 2025 /EINPresswire.com/ -- Suffescom Solutions has built a strong position as a leading company with more than 11+ years of experience in top-notch mobile app development. We are taking the step ahead by delivering …
PacBio Grants Equity Incentive Award to New Employee
GlobeNewswire
·
April 4, 2025
MENLO PARK, Calif., April 04, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced that the Compensation Committee of the Company’s Board of Directors granted a non- …
Industry Titans to Speak at Paris Blockchain Week 2025
EIN Presswire
·
April 4, 2025
PARIS, FRANCE, April 4, 2025 /EINPresswire.com/ -- Paris Blockchain Week, the premier global event for blockchain professionals, reveals the first six headline speakers for its sixth edition, which will take place from April 8-10th, 2025, at the …
Paris Blockchain Week 2025 Introduces New Hybrid Hackathon to Build the Future of Blockchain
EIN Presswire
·
April 4, 2025
PARIS, FRANCE, April 4, 2025 /EINPresswire.com/ -- Paris Blockchain Week, Europe’s flagship Web3 event “where business happens,” announces its 2025 Hackathon, a dynamic competition designed to bring together global developers to create innovative …
Kevin O’Leary & Dr. Farb in a Webinar
EIN Presswire
·
April 4, 2025
Kevin O'Leary and Flower Turbines CEO Dr. Farb Discuss Wind, Renewable Energy, and Data Centers on April 10 LUBBOCK, TX, UNITED STATES, April 4, 2025 /EINPresswire.com/ -- Kevin O’Leary (aka Mr. Wonderful) and Flower Turbines’ CEO, Dr. Daniel Farb will …
Bitcoin Mining Made Easier: How ZA Miner Eliminates Bitcoin Mining Barriers Through AI-driven Cloud Mining
GlobeNewswire
·
April 4, 2025
Middlesex, UK, April 04, 2025 (GLOBE NEWSWIRE) -- Revolutionary Platform Allows Users to Earn Effortlessly While Focusing on Life’s Priorities In a world where financial freedom often feels out of reach, ZA Miner is changing the game with its …
BitMart Joins Global Dollar Network to Advance Trusted Stablecoin Adoption
GlobeNewswire
·
April 4, 2025
Mahe, Seychelles, April 04, 2025 (GLOBE NEWSWIRE) -- BitMart, a global leader in cryptocurrency trading, is proud to announce its strategic partnership with Paxos, the issuer of Global Dollar (USDG), through its participation in the Global Dollar Network …
AIM ImmunoTech Announces NYSE American Notice of Delisting and Appeal
GlobeNewswire
·
April 4, 2025
OCALA, Fla., April 04, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (“AIM” or the “Company”) (NYSE American: AIM), an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders and …
Alumis and ACELYRIN File Joint Definitive Proxy Statement for Proposed Merger
GlobeNewswire
·
April 4, 2025
Stockholders to benefit from differentiated late-stage portfolio of therapies and strong balance sheet Boards unanimously recommend stockholders vote “FOR” the merger Transaction expected to be completed in second quarter of 2025 SOUTH SAN FRANCISCO, Calif …
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 4, 2025
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, April 04, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced …
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 4, 2025
WALTHAM, Mass., April 04, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced that, …
Eros Resources Closes Oversubscribed $2.1 million Private Placement Financing
GlobeNewswire
·
April 4, 2025
Vancouver, BC, April 04, 2025 (GLOBE NEWSWIRE) -- Eros Resources Corp. (TSXV: ROCK) (OTCQB: EROSF) (“Eros” or the “Company”) is pleased to announce the closing of its private placement of C$2,077,500 (the "Financing"), which represents an oversubscription …
Edesa Biotech Announces Chief Financial Officer Transition
GlobeNewswire
·
April 4, 2025
TORONTO, April 04, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, today announced the appointment of Peter J. Weiler …
Pivotal Helix Wins Gold 2025 Edison Award
GlobeNewswire
·
April 4, 2025
PALO ALTO, Calif., April 04, 2025 (GLOBE NEWSWIRE) -- Pivotal, the market leader in light electric vertical takeoff and landing (eVTOL) aircraft, today announced it was recognized with the prestigious Gold 2025 Edison Award in The Future of Personal Flight …
Mersana Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 4, 2025
CAMBRIDGE, Mass., April 04, 2025 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of high …
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
GlobeNewswire
·
April 4, 2025
NEW YORK, April 04, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that on April 1, 2025 the Company granted inducement …
Adverum Biotechnologies Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 4, 2025
REDWOOD CITY, Calif., April 04, 2025 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM) today announced that the Compensation Committee of Adverum’s Board of Directors granted an inducement award consisting of non-qualified stock options to …
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 4, 2025
NAARDEN, the Netherlands and MIAMI, April 04, 2025 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients …
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 4, 2025
WESTLAKE VILLAGE, Calif., April 04, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today reported the grant of an …